financetom
Business
financetom
/
Business
/
US startup Lyten to buy bankrupt European battery maker Northvolt
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US startup Lyten to buy bankrupt European battery maker Northvolt
Aug 7, 2025 8:11 AM

*

Lyten gives no purchase price for the acquisition

*

Lyten backed by Jeep-owner Stellantis ( STLA ) and FedEx ( FDX )

*

Lyten CEO expects battery cell deliveries to resume in

2026

*

Deal includes Northvolt's projects in Sweden and Germany

(Adds comments from bankruptcy trustee and Sweden's deputy

prime minister in paragraph 5, also adds Scania in paragraph 7)

By Marie Mannes

STOCKHOLM, Aug 7 (Reuters) - U.S. battery startup Lyten

has agreed to buy most of bankrupt Swedish battery maker

Northvolt, it said on Thursday, potentially offering a way back

for the European company that was once seen as the region's

answer to rivals in Asia.

Lyten, a Silicon Valley battery startup developing

lithium-sulphur cells as a cleaner alternative to lithium-ion,

is backed by Jeep-owner Stellantis ( STLA ) and U.S. delivery

services provider FedEx ( FDX ).

The deal revives hopes for European battery independence

after Northvolt - the continent's potential rival to major

Chinese electric vehicle battery makers - filed for bankruptcy

in March, making it one of Sweden's largest corporate failures

and sparking a frantic push to find a buyer.

"Our plans are ... in large part to pick up where the

Northvolt team left off," Lyten CEO and co-founder Dan Cook told

Reuters, declining to disclose the purchase price beyond saying

it was at a "substantial discount" to the original asset value.

Northvolt's bankruptcy trustee said that the deal defused

the risk of "complete shutdown", while Sweden's deputy prime

minister Ebba Busch said the deal positioned the country "as key

to Europe's energy independence.

Northvolt has received much criticism that it had

overpromised while failing to deliver battery cells deemed good

enough quality for clients, even with help from its biggest

customer, truckmaker Scania.

Gustaf Sundell, Scania's head of ventures and new business,

told Reuters it was too early to say if the group would place

orders for batteries with Lyten, but it was happy with the

outcome.

TARGET MARKETS

Lyten hopes to quickly restart the flagship Skelleftea plant

in northern Sweden and resume deliveries of lithium-ion battery

cells in 2026. In July it acquired Northvolt's energy storage

business in Poland, Europe's largest, and is targeting

automotive, defence and energy storage markets.

Cook said several of Northvolt's former management would be

joining Lyten, though not founder and ex-CEO Peter Carlsson.

"We are focused on developing to be the leaders in locally

sourced, locally manufactured batteries for both the North

American and European markets right now," he said.

Lyten said in July it had secured more than $200 million in

additional equity investment to support its acquisitions and

expansion plans.

Cook said Lyten would prove its worth to Northvolt's former

customers by focusing first on providing high yields to a single

customer. Northvolt's order book once totalled more than $50

billion from automakers such as BMW, Volkswagen

and Audi.

"We actually think they'll come back, perhaps quicker than

people believe," said Cook.

The deal includes Northvolt's projects in Sweden and

Germany, as well as its intellectual property. Work was also

underway to acquire its Canadian unit.

Before its collapse, Northvolt expanded across the Atlantic

but later refocused on Sweden as its financial crisis deepened,

selling assets for nominal sums.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Biogen, Eisai Submit Biologics License Application for Alzheimer's Subcutaneous Autoinjector to US FDA
Biogen, Eisai Submit Biologics License Application for Alzheimer's Subcutaneous Autoinjector to US FDA
Nov 3, 2024
08:13 AM EDT, 11/01/2024 (MT Newswires) -- Biogen (BIIB) and Eisai said late Thursday that Eisai finalized a biologics license application rolling submission to the FDA for a subcutaneous autoinjector of LEQEMBI, or lecanemab-irmb, for weekly dosing in early-stage Alzheimer's disease. The device, which is designed for home or clinic use, allows a 15-second injection and supports sustained drug levels...
Cboe beats third-quarter profit estimates on strong hedging activity
Cboe beats third-quarter profit estimates on strong hedging activity
Nov 3, 2024
Nov 1 (Reuters) - Cboe Global Markets ( CBOE ) beat estimates for third-quarter profit on Friday, helped by strong options trading as investors actively hedged against geopolitical and economic uncertainties. A robust equities market, shifts in the U.S. Federal Reserve's key policy rates and the potential economic fallout from the Middle East conflict have investors and portfolio managers on...
--Dominion Energy Keeps Quarterly Dividend at $0.6675 per Share, Payable Dec. 20 to Holders of Record Nov. 29
--Dominion Energy Keeps Quarterly Dividend at $0.6675 per Share, Payable Dec. 20 to Holders of Record Nov. 29
Nov 3, 2024
03:17 PM EDT, 10/31/2024 (MT Newswires) -- Price: 59.73, Change: +1.28, Percent Change: +2.18 ...
Cardinal Health lifts annual profit outlook on strength in specialty medicines unit
Cardinal Health lifts annual profit outlook on strength in specialty medicines unit
Nov 3, 2024
Nov 1 (Reuters) - Cardinal Health ( CAH ) raised its 2025 adjusted profit forecast on Friday as strong demand for costly specialty medicines and branded drugs drove sales at its pharmaceuticals unit, sending the shares of the company up nearly 4% in premarket trading. Drug distributors have been trying to diversify their operations and gain better footing in the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved